share

5,9,10,14B-Tetrahydro-5,10-Dimethylisoquino[2,1-D][1,4]Benzodiazepin-6(7H)-One CAS NO 67239-21-8


Unit Price:

CAS No.:67239-21-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

5,9,10,14B-Tetrahydro-5,10-Dimethylisoquino[2,1-D][1,4]Benzodiazepin-6(7H)-One is a high-purity, complex heterocyclic organic compound with a fused benzodiazepine-isoquinoline structure. This specialized chemical serves as a critical pharmaceutical intermediate and a valuable scaffold in medicinal chemistry research for developing novel therapeutic agents. It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of advanced active pharmaceutical ingredients (APIs).

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of complex drug molecules, particularly those targeting the central nervous system.
  • Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and the development of new chemical entities (NCEs).
  • Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
  • Biochemical Research: Employed in studies investigating ligand-receptor interactions, particularly with benzodiazepine receptor sites.
  • Process Development: Utilized in the optimization and scale-up of synthetic routes for advanced pharmaceutical manufacturing.

Basic Information

Product Name 5,9,10,14B-Tetrahydro-5,10-Dimethylisoquino[2,1-D][1,4]Benzodiazepin-6(7H)-One
CAS No. 67239-21-8
Molecular Formula C19H18N2O
Molecular Weight 290.36 g/mol
Synonyms 5,10-Dimethyl-5,9,10,14b-tetrahydroisoquino[2,1-d][1,4]benzodiazepin-6(7H)-one; 5,10-Dimethyl-6,7-dihydro-5H-isoquino[2,1-d][1,4]benzodiazepin-6-one; 67239-21-8; Isoquino[2,1-d][1,4]benzodiazepin-6(7H)-one, 5,9,10,14b-tetrahydro-5,10-dimethyl-
EINECS Contact for details

Quality Control

Our production of 5,9,10,14B-Tetrahydro-5,10-Dimethylisoquino[2,1-D][1,4]Benzodiazepin-6(7H)-One adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. All materials are subjected to comprehensive analytical characterization using techniques such as HPLC, NMR, and MS. A Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment, supporting compliance in regulated research and development environments.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain product integrity.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.